Rationale for WHO's New Position Calling for Prompt Reporting and Public Disclosure of Interventional Clinical Trial Results

Por Moorthy, Vasee S., Karam, Ghassan, Vannice, Kirsten S., Kieny, Marie-Paule
Publicado no PLoS Med (2015)

Variant ionotropic glutamate receptors as chemosensory receptors in Drosophila

Por Benton, Richard, Vannice, Kirsten S., Gomez-Diaz, Carolina, Vosshall, Leslie B.
Publicado em 2009

MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines

Por Vannice, Kirsten S, Brown, Graham V, Akanmori, Bartholomew D, Moorthy, Vasee S
Publicado em 2012

The Association Between Intentional Delay of Vaccine Administration and Timely Childhood Vaccination Coverage

Por Smith, Philip J., Humiston, Sharon G., Parnell, Trish, Vannice, Kirsten S., Salmon, Daniel A.
Publicado em 2010

Attitudes and Beliefs of Parents Concerned About Vaccines: Impact of Timing of Immunization Information

Por Vannice, Kirsten S., Salmon, Daniel A., Shui, Irene, Omer, Saad B., Kissner, Jennifer, Edwards, Kathryn M., Sparks, Robert, Dekker, Cornelia L., Klein, Nicola P., Gust, Deborah A.
Publicado no Pediatrics (2011)

Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013

Por Diomandé, Fabien V. K., Yaméogo, Téné M., Vannice, Kirsten S., Preziosi, Marie-Pierre, Viviani, Simonetta, Ouandaogo, Claude-Roger, Keita, Modibo, Djingarey, Mamoudou H., Mbakuliyemo, Nehemie, Akanmori, Bartholomew Dicky, Sow, Samba O., Zuber, Patrick L. F.
Publicado no Clin Infect Dis (2015)

Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali

Por Vannice, Kirsten S., Keita, Modibo, Sow, Samba O., Durbin, Anna P., Omer, Saad B., Moulton, Lawrence H., Yaméogo, Téné M., Zuber, Patrick L. F., Onwuchekwa, Uma, Sacko, Massambou, Diomandé, Fabien V. K., Halsey, Neal A.
Publicado no Clin Infect Dis (2015)

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines

Por Black, Steven, Eskola, Juhani, Siegrist, Claire-Anne, Halsey, Neal, MacDonald, Noni, Law, Barbara, Miller, Elizabeth, Andrews, Nick, Stowe, Julia, Salmon, Daniel, Vannice, Kirsten, Izurieta, Hector S, Akhtar, Aysha, Gold, Mike, Oselka, Gabriel, Zuber, Patrick, Pfeifer, Dina, Vellozzi, Claudia
Publicado em 2009

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study

Por Flasche, Stefan, Jit, Mark, Rodríguez-Barraquer, Isabel, Coudeville, Laurent, Recker, Mario, Koelle, Katia, Milne, George, Hladish, Thomas J., Perkins, T. Alex, Cummings, Derek A. T., Dorigatti, Ilaria, Laydon, Daniel J., España, Guido, Kelso, Joel, Longini, Ira, Lourenco, Jose, Pearson, Carl A. B., Reiner, Robert C., Mier-y-Terán-Romero, Luis, Vannice, Kirsten, Ferguson, Neil
Publicado no PLoS Med (2016)